Company
About us
History
Leadership
Location
SCIENCE
PIPELINE
ACART
PUBLICATION
INVESTORS
Notice
Financial Info
IR Material
Press Releases
Public Disclosures
SUSTAINABILITY
Governance
Code of Ethics
Board
Committee
Audit
Articles of Inc.
ESG Portal
Contact
Contact us
Report a Concern
Privacy Policy
Careers
a
English
M
English
COMPANY
About us
History
Leadership
Location
SCIENCE
PIPELINE
ACART
Publication
INVESTORS
Notice
Financial Info
IR Material
Press Releases
Public Disclosures
Sustainability
Governance
Code of Ethics
Board
Committee
Audit
Articles of Inc.
ESG Portal
CONTACT
Contact us
Report a Concern
Privacy Policy
Careers
English
March 24, 2026
Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML
By: Oscotec 오스코텍 2026
Attachment File
List
